STAT3 and T-cell large granular lymphocyte leukemia: Constitutive activation of the STAT3 pathway is a hallmark of T-LGL leukemia pathobiology [13,43], and STAT3 mutations were detected in 27–72% of patients with T-LGL leukemia [13,44,45,46].